Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma

Robert J. Motzer, Naomi B. Haas, Frede Donskov, Marine Gross-Goupil, Sergei Varlamov, Evgeny Kopyltsov, Jae Lyun Lee, Bohuslav Melichar, Brian I. Rini, Toni K. Choueiri, Milada Zemanova, Lori A. Wood, M. Neil Reaume, Arnulf Stenzl, Simon Chowdhury, Ho Yeong Lim, Ray McDermott, Agnieszka Michael, Weichao Bao, Marlene J. Carrasco-AlfonsoPaola Aimone, Maurizio Voi, Christian Doehn, Paul Russo, Cora N. Sternberg

Research output: Contribution to journalArticlepeer-review

331 Citations (Scopus)
Original languageEnglish
Pages (from-to)3916-3923
Number of pages8
JournalJournal of Clinical Oncology
Volume35
Issue number35
DOIs
Publication statusPublished - Dec 10 2017

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma'. Together they form a unique fingerprint.

Cite this